Almirall Reports Strong Q3 2024 Results Driven by Biologics Growth
Almirall, S.A. (ALM), a global biopharmaceutical company based in Barcelona, today reported its financial results for the first nine months of 2024. The company posted strong sales growth, primarily driven by its dermatology business, particularly the biologics portfolio in Europe.…
Oncoinvent Announces Promising Interim Results for Radspherin® in Peritoneal Carcinomatosis Treatment
Oncoinvent ASA, a clinical-stage company developing alpha emitter therapies for solid cancers, today reported interim data from the Phase 1/2a trials of Radspherin® for the treatment of peritoneal carcinomatosis. Recruitment for these studies concluded at the end of 2023, with…
Novotech Wins 2024 Clinical Trials Arena Excellence Award for Business Development and Innovation
Novotech, a full-service global contract research organization (CRO), has been honored with multiple awards at the 2024 Clinical Trials Arena Excellence Awards. These prestigious accolades recognize Novotech’s achievements in business development, innovation, and marketing, underscoring the company’s commitment to advancing…
A2 Bio Highlights Tmod™ CAR T-Cell Progress at 2024 SITC Annual Meeting
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing innovative logic-gated cell therapies to selectively target tumor cells while sparing normal cells, today presented updates on its Tmod™ CAR T-cell clinical programs at the 39th Annual Meeting of…
Lindora Celebrates National Nurse Practitioner Week with Special Offers
In recognition of National Nurse Practitioner Week (November 10-16), Lindora is honoring the contributions of nurse practitioners and wellness professionals with a special offer. There are over 385,000 nurse practitioners (NPs) licensed in the U.S., according to the American Association…
Chemed Board Approves $300M Stock Repurchase and 50¢ Quarterly Dividend
Chemed Corporation (NYSE: CHE) today announced that its Board of Directors has authorized an additional $300 million for stock repurchases under the company’s existing share repurchase program. These repurchases will be funded with a mix of cash generated from operations…
Henry Schein Medical Supports Healthcare Professionals During Diabetes Awareness Month
November marks American Diabetes Month®, an important time to raise awareness about diabetes and support the 1.2 million new diabetes diagnoses in the U.S. each year, along with the more than 38 million Americans living with the disease. To help…
Butterfly iQ3™ Wins Best Medical Technology at 2024 Prix Galien USA Awards
Butterfly Network, Inc. (NYSE: BFLY), a leader in digital health and portable ultrasound technology, has announced that its third-generation handheld ultrasound device, the Butterfly iQ3™, has been honored with the Best Medical Technology Award at the 2024 Prix Galien USA…
Tempus to Present Nine Abstracts at 2024 SITC Annual Meeting
Tempus AI, Inc. (NASDAQ: TEM), a leader in applying artificial intelligence to drive advancements in precision medicine and patient care, today announced that nine of its abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer’s (SITC)…
Mirum Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced that on November 8, 2024, its Compensation Committee granted inducement awards to seven new employees under the company’s 2020 Inducement Plan. These awards consist of non-qualified stock options to purchase 56,100 shares of common…
Baxter Reports Q3 2024 Results
Baxter International Inc. (NYSE: BAX), a global leader in medical technology, announced today its financial results for the third quarter of 2024, highlighting strong performance despite ongoing challenges. “Despite facing some headwinds, Baxter delivered positive results in the third quarter…
Cencora Expands Specialty Leadership with Acquisition of Retina Consultants of America
Cencora, Inc. (NYSE: COR), a global leader in pharmaceutical solutions, today announced it has entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading management services organization (MSO) for retina specialists, from Webster Equity Partners. The…